XNAS
TOIIW
Market cap236mUSD
Jun 12, Last price
0.07USD
1D
-6.81%
1Q
204.27%
IPO
-97.13%
Name
Oncology Institute Inc
Chart & Performance
P/E
—
P/S
0.02
EPS
—
Div Yield, %
—
Shrs. gr., 5y
310.41%
Rev. gr., 5y
20.41%
Revenues
393m
+21.33%
Net income
-65m
L-22.16%
CFO
-27m
L-26.92%
Earnings
Aug 11, 2025
Profile
DFP Healthcare Acquisitions Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization or other similar business combination. The company was founded in 2019 and is based in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 393,412 21.33% | 324,239 28.42% | 252,483 24.37% | ||||
Cost of revenue | 264,666 | 200,390 | |||||
Unusual Expense (Income) | |||||||
NOPBT | 393,412 | 59,573 | 52,093 | ||||
NOPBT Margin | 100.00% | 18.37% | 20.63% | ||||
Operating Taxes | (36) | 247 | |||||
Tax Rate | 0.47% | ||||||
NOPAT | 393,412 | 59,609 | 51,846 | ||||
Net income | (64,663) -22.16% | (83,068) -5,113.16% | 1,657 -115.16% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 75 | (893) | (8,142) | ||||
BB yield | 0.00% | 0.59% | 6.12% | ||||
| Debt | |||||||
Debt current | 6,798 | 6,363 | 5,498 | ||||
Long-term debt | 53,244 | 146,161 | 130,239 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 93,658 | 4,115 | 5,981 | ||||
Net debt | 10,373 | 69,669 | 3,577 | ||||
| Cash flow | |||||||
Cash from operating activities | (26,538) | (36,315) | (61,756) | ||||
CAPEX | (3,789) | (4,567) | (5,529) | ||||
Cash from investing activities | 46,211 | 62,640 | (131,614) | ||||
Cash from financing activities | (3,492) | (6,847) | 92,206 | ||||
FCF | 414,724 | 48,681 | 794 | ||||
| Balance | |||||||
Cash | 49,669 | 82,855 | 73,806 | ||||
Long term investments | 58,354 | ||||||
Excess cash | 29,998 | 66,643 | 119,536 | ||||
Stockholders' equity | (210,805) | (146,142) | (61,570) | ||||
Invested Capital | 338,073 | 326,957 | 300,023 | ||||
ROIC | 118.31% | 19.01% | 19.32% | ||||
ROCE | 309.04% | 32.95% | 21.80% | ||||
| EV | |||||||
Common stock shares outstanding | 75,043,678 | 73,749 | 80,606 | ||||
Price | 0.31 -84.85% | 2.04 23.64% | 1.65 -83.08% | ||||
Market cap | 23,188,497 15,313.04% | 150,447 13.12% | 132,999 -79.40% | ||||
EV | 23,198,870 | 220,116 | 136,576 | ||||
EBITDA | 399,699 | 65,446 | 56,504 | ||||
EV/EBITDA | 58.04 | 3.36 | 2.42 | ||||
Interest | 7,496 | 6,777 | 4,082 | ||||
Interest/NOPBT | 1.91% | 11.38% | 7.84% | ||||